Company Name Avrobio
Mailing Address 400 Technology Square 10th Floor Cambridge, MA 02139 USA
Company Description AVROBIO is a clinical stage company developing step-change cell and gene therapies targeting cancer and rare disease. The catalyst for creating AVROBIO is to accelerate scientific breakthroughs related to the convergence of cell and gene therapies.
Proceeds Purposes AVROBIO will use the proceeds from this financing to accelerate development of its clinical stage programs in Fabry disease and acute myeloid leukemia (AML), and to expand its pipeline in rare diseases and solid and liquid cancers.